New insights into atypical Alzheimer's disease in the era of biomarkersJonathan Graff‐Radford, Melissa E. Murray|The Lancet Neurology|2021Cited by 647
Cross–scanner harmonization methods for structural MRI may need further work: A comparison studyRobel K Gebre, Prashanthi Vemuri, Matthew L. Senjem et al.|NeuroImage|2023Cited by 41
White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer DiseaseJianqiao Tian, Prashanthi Vemuri, Clifford R. Jack et al.|Neurology|2023Cited by 27
Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosisVijay K. Ramanan, Prashanthi Vemuri, Robel K Gebre et al.|Brain|2023Cited by 24
Vascular risk, gait, behavioral, and plasma indicators of VCIDSheelakumari Raghavan, Prashanthi Vemuri, Scott A. Przybelski et al.|Alzheimer s & Dementia|2023Cited by 16